申请人:FUJIREBIO INC.
公开号:US11169162B2
公开(公告)日:2021-11-09
Disclosed is a method of measuring the prostaglandin E main urinary metabolite (PGE-MUM), in which a mixture solution of a urine sample treated with alkali can directly be subjected to an antigen-antibody reaction system in an immunoassay of PGE-MUM, without neutralization and dilution followed by dispensation. The method of measuring PGE-MUM includes the steps of: a) mixing a urine sample with an alkaline aqueous solution, and b) subjecting the mixture solution resulting from a) to an immunoassay using a bicyclo PGE-MUM-immobilized or anti-bicyclo PGE-MUM antibody-immobilized solid phase to measure PGE-MUM in the urine sample, wherein the immunoassay is performed in a weakly-acidic basal buffer solution in the presence of a second pH buffering agent which exerts a buffering effect in the basic range and is different from the pH buffering agent contained in the basal buffer solution, and in the presence of a cationic surfactant.
本发明公开了一种前列腺素 E 主要尿液代谢物(PGE-MUM)的测定方法,在该方法中,尿样经碱处理后的混合溶液可直接在抗原-抗体反应系统中进行 PGE-MUM 的免疫测定,无需中和稀释后再进行分装。测量 PGE-MUM 的方法包括以下步骤:a)将尿样与碱性水溶液混合,和 b)将 a)产生的混合溶液进行免疫测定,使用双环 PGE-MUM- 固定化或抗双环 PGE-MUM 抗体-固定化固相来测量尿样中的 PGE-MUM、其中,免疫测定是在弱酸性基础缓冲溶液中,在第二种 pH 缓冲剂的存在下进行的,第二种 pH 缓冲剂在碱性范围内发挥缓冲作用,与基础缓冲溶液中所含的 pH 缓冲剂不同,并且在阳离子表面活性剂的存在下进行。